A new study published from Health Affairs finds Medicare Part D patients paid 10.5 times as much in co-payments for brand-name drugs as generic drugs, Kaiser Health News reported.
Payer
Milwaukee-based Children's Hospital and Health System will sell its Children's Community Health Plan through the Affordable Care Act marketplace, The Milwaukee Journal Sentinel reported.
A recent study published in Health Affairs found states that legalized medical marijuana saw a slight decrease in Medicare prescription use and Medicare Part D spending, Kaiser Health News reported.
Connecticut Attorney General George Jepsen voiced concern about a $54 billion deal between Indianapolis-based Anthem and Bloomfield, Conn.-based Cigna in an interview with the Hartford Courant Thursday.
Hartford, Conn.-based Aetna's proposed $37 billion acquisition of Louisville, Ky.-based Humana faces major pushback from the U.S. Department of Justice, which reportedly voiced significant concerns about the deal.
Advertisement
Baltimore-based Evergreen Health Cooperative will shell out $24.2 million in risk adjustment fees to its largest competitor under the Affordable Care Act's Risk Adjustment Program, The Baltimore Sun reported.
Through a combination of funds recovered and losses avoided, Horizon Blue Cross Blue Shield of New Jersey's anti-fraud unit yielded $43.2 million in savings in 2015, according to a statement released Wednesday.
The following insurers made headlines this week. They are listed below, beginning with the most recent.
A recent study from the University of North Carolina at Chapel Hill revealed specialty drug costs for payers have tripled since 2003, when they represented 11 percent of payer drug spending.
HHS found 11.1 million — over 87 percent — of the 12.7 million Americans who purchased coverage on public health insurance exchanges in 2016 paid their premiums and maintained coverage, Business Insurance reported.